Drug Type Small molecule drug |
Synonyms LXH-1211, LXH-12119 |
Target |
Action inhibitors, stimulants |
Mechanism AMPK inhibitors(AMP活化蛋白激酶抑制剂), sGC stimulants(Soluble guanylate cyclase stimulants) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization |
Drug Highest PhaseIND Approval |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Pulmonary Arterial Hypertension | IND Approval | China | 24 Sep 2025 | |
| Hypertension, Pulmonary | Preclinical | China | 21 Dec 2020 |





